Sympathetic activity and body mass index contribute to blood pressure levels

Hypertension Research

Volumn 23, Issue 4, 2000, Pages 303-310

  Masuo, Kazuko ^a   Mikami, Hiroshi ^a   Itoh, Mikiko ^a   Ogihara, Toshio ^a   Tuck, Michael L ^b  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Blood pressure; Body mass index; Insulin; Leptin; Obesity; Sympathetic activity

Indexed keywords

INSULIN; LEPTIN;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CONTROLLED STUDY; DIET RESTRICTION; HORMONE DETERMINATION; HUMAN; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NORADRENALIN BLOOD LEVEL; OBESITY; PULSE RATE; REGRESSION ANALYSIS; SYMPATHETIC TONE;

EID: 0033921045     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.23.303     Document Type: Article

References (45)

1. Dustan HP: Mechanisms of hypertension associated with obesity. Ann Intern Med 1983; 98 (Part 2): 860-864.
2. Hubert HB, Feinleib M, McNamara PM, Castelli WP: Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67: 968-977.
3. Van Itallie TB: Health implications of overweight and obesity in the United States. Ann Intern Med 1985; 103: 983-988.
4. Tuck ML: Obesity, the sympathetic nervous system, and essential hypertension. Hypertension 1992; 19 (Suppl I): I-67-I-77.
5. Grassi G, Seravalle G, Cattaneo BM, et al: Sympathetic activation in obese normotensive subjects. Hypertension 1995; 25 (Part 1): 560-563.
6. Vaz M, Jenning G, Turner A, Cox H, Lambert G, Esler M: Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation 1997; 96: 3423-3429.
7. Mark AL, Correia M, Morgan DA, Shaffer RA, Haynes WG: Obesity-induced hypertension. New concepts from the emerging biology of obesity. Hypertension 1999; 33 (Part II): 537-541.
8. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI: Receptor mediated regional sympathetic nerve activation by leptin. J Clin Invest 1997; 15: 270-278.
9. Rumantir MS, Vaz M, Jenning GL, et al: Neural mechanisms in human obesity-related hypertension. J Hypertens 1999; 17: 1-9.
10. Masuo K, Mikami H, Ogihara T, Tuck ML: Differences in sympathetic activity in obese hypertensives with and without BP reduction caused by body weight reduction. Circulation 1997; 96 (Suppl I): I-33.
11. Sims EAH: Mechanisms of hypertension in the overweight. Hypertension 1982; 4 (Suppl III): III-43-III-49.
12. Landsberg L: Hyperinsulinemia: possible role in obesity-induced hypertension. Hypertension 1992; 19 (Suppl I): I-61-I-66.
13. Gudbjornsdottir S, Elam M, Seligen J, Anderson EA: Insulin increases forearm vascular resistance in obese, insulin-resistant hypertensives. J Hypertens 1996; 14: 91-97.
14. Ikeda T, Gomi T, Hirawa N, Sakurai J, Yoshikawa N: Improvement of insulin sensitivity contributes to blood pressure reduction after weight loss in hypertensive subjects with obesity. Hypertension 1996; 27: 1180-1186.
15. Meehan WP, Buchanan TA, Hsueh W: Chronic insulin administration elevates blood pressure in rats. Hypertension 1994; 23 (Part 2): 1012-1017.
16. Kawabe H, Saito I, Nishino M, Wainai H, Nagano S, Saruta T: Hyperinsulinemia in obese and non-obese young Japanese hypertensive men. Hypertens Res 1994; 17: 133-136.
17. Takisita S, Abe I, Kobayashi K, et al: Insulin and cardiovascular disease in Japanese work-site population with borderline to mild hypertension. Hypertens Res 1996; 19: S13-S18.
18. Agata J, Miyazaki N, Takada M, et al: Association of insulin resistance and hyperinsulinemia with disturbed lipid metabolism in patients with essential hypertension. Hypertens Res 1998; 21: 57-62.
19. Young JB, Macdonald IA: Sympathoadrenal activity in human obesity: heterogeneity of findings since 1980. Int J Obes Relat Metab Disord 1992; 16: 959-967.
20. Halaas JL, Gajiwala KS, Maffei M, et al: Weight-reducing effects of plasma protein encoded by the obese gene. Science 1995; 269: 543-546.
21. Woods AJ, Stock MJ: Leptin activation in hypothalamus. Nature 1996; 381: 745.
22. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P: Recombinant mouse OB protein: evidence for peripheral signal linking adiposity and central neural networks. Nature 1995; 269: 546-549.
23. Narkiewicz K, Somers V, Mos L, Kato M, Accurso V, Palatini P: An independent relationship between plasma leptin and heart rate in untreated patients with essential hypertension. J Hypertens 1999; 17: 245-249.
24. Narkiewicz K, Szczech R, Winnicki M, et al: Heritability of plasma leptin levels: a twin study. J Hypertens 1999; 17: 27-31.
25. Poehlman ET, Gardner AW, Goran MI, et al: Sympathetic nervous system activity, body fatness and body fat distribution in younger and older males. J Appl Physiol 1995; 78: 802-806.
26. Ostlund RE Jr, Yang JW, Klein S, Gingerich R: Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates. J Clin Endocrinol Metab 1996; 81: 3909-3913.
27. Haynes WG, Morgan DA, Waldsh SA, Mark AL, Sivitz WI: Leptin increases sympathetic nerve activity to brown adipose tissue and kidney. FASEB 1997; 11: A4.
28. Masuo K, Mikami H, Ogihara T, Tuck ML: Do reduced insulin sensitivity and dyslipidemia exist in borderline hypertensive patients? Am J Hypertens 1996; 9: 566-569.
29. Agata J, Masuda A, Takada M,: High plasma immunoreactive leptin level in essential hypertension. Am J Hypertens 1997; 10: 1171-1174.
30. Hopkins PN, Hunt SC, Wu LL, Williams GH, Williams RR: Hypertension, dyslipidemia, and insulin resistance: links in chain or spokes on a wheel? Curr Opin Lipidol 1996; 7: 241-253.
31. Nakamura Y, Kakoki M, Yamakado M: The effect of age on glucose tolerance and plasma insulin level in hypertensive and normotensive subjects. Hypertens Res 1996; 19: S23-S26.
32. Reams G, Villarreal D, Taraben A, Freeman RH, Knoblich P: Renal effects of leptin in normotensive and spontaneous hypertensive rats. FASEB 1997; 11: A258.
33. Jackson EK, Li P: Human leptin may function as a diuretic/natriuretic hormone. Hypertension 1996; 28: 517.
34. Shek EW, Brands MW, Hall JE: Chronic leptin infusion increases arterial pressure. Hypertension 1998; 31 (Part 2): 409-414.
35. Collins S, Kuhn CM, Petro AE, Swick AG, Chrunyk BA, Surwit RS: Role of leptin in fat regulation. Nature 1996; 380: 677 (Letter).
36. Christin L, O'Connell M, Bogardus C, Danforth E Jr, Ravussin E: Norepinephrine turnover and energy expenditure in Pima Indian and white men. Metabolism 1993; 42: 723-729.
37. Stephrens TW, Basinski M, Bristrow PK, et al: The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 1995; 377: 530-532.
38. Kolaczynski JW, Nyce MR, Considine RV, et al: Acute and chronic effect of insulin on leptin production in humans. Diabetes 1996; 45: 699-701.
39. Malmstrom R, Taskinen MR, Karonen SL, Yki-Jarvinen H: Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM. Diabetologia 1996; 39: 993-996.
40. Muscelli E, Camastra S, Masoni A, et al: Acute insulin administration does not affect plasma leptin levels in lean or obese subjects. Eur J Clin Invest 1996; 26: 940-943.
41. Hildebrandt DA, Smith Jr MJ, Hall JE: Cardiovascular regulation during insulin infusion into the carotid or vertebral artery in dogs. J Hypertens 1999; 17: 251-260.
42. Alonso-Galicia M, Brands MW, Zappe DH, Hall JE: Hypertension in obese zucker rats; Role of angiotensin II and adrenergic activity. Hypertension 1996; 28: 1047-1054.
43. Vollenweider P, Randin D, Tappy L, Jequier E, Nicod P, Scherrer U: Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. J Clin Invest 1994; 93: 2365-2371.
44. Masuo K, Mikami H, Ogihara T, Tuck ML: Changes in plasma leptin, insulin and sympathetic activity during long-term treatment with ACE-inhibitor and calcium channel blocker in obese hypertensives. J Hypertens 1999; 17 (Suppl 3): S3.
45. Grassi G, Esler M: How to assess sympathetic activity in humans. J Hypertens 1999; 17: 719-734.